INSM Trading Analysis - 09/10/2026 04:29 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for INSM include:

• Insmed Incorporated (INSM) announced positive topline results from its CONVERT trial of brensocatib in patients with bronchiectasis.
• The company reported that the trial met its primary endpoint, showing a significant reduction in pulmonary exacerbations.
• INSM's stock has been gaining momentum following the announcement, with increased investor interest.

These headlines suggest a positive catalyst for INSM's stock price, aligning with the bullish sentiment observed in the technical and options data.

Fundamental Analysis:

Revenue Growth: Not provided in the data.

Profit Margins: Gross margin: 83.46%, Operating margin: -73.89%, Net margin: -76.94%. The negative operating and net margins indicate significant losses.

Earnings Per Share (EPS): Trailing EPS: -4.10. The negative EPS suggests the company is currently unprofitable.

P/E Ratio: Trailing P/E: -31.41. The negative P/E ratio reflects the company's unprofitable status.

Debt/Equity: 0.72. The debt-to-equity ratio is relatively moderate, but the company's profitability issues are a concern.

Return on Equity (ROE): -1.16. The negative ROE indicates that the company is not generating profits from shareholders' equity.

Fundamentally, INSM shows significant challenges with profitability, but the recent positive news and technical indicators suggest a potential turnaround.

Current Market Position:

Current Price: $127.28

Recent Price Action: The stock has shown a recent uptrend, with a significant increase in price over the past few weeks.

Support and Resistance: Key support levels observed at $125.00 and $120.00. Resistance levels at $130.00 and $135.00.

Intraday Momentum: The minute bars show a stable intraday trend with minor fluctuations.

Technical Analysis:

SMA Trends: The 50-day SMA ($117.02) is below the current price, indicating a bullish trend.

RSI: RSI is at 54.42, which is neutral but leaning towards the upper side, suggesting some bullish momentum.

MACD: The MACD is bullish, indicating upward momentum.

Bollinger Bands: The current price is near the upper band, suggesting potential overbought conditions but also strong upward momentum.

30-day High/Low: The stock is near its 30-day high, indicating strong recent performance.

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Bullish

Call vs Put Dollar Volume: Call dollar volume: $6766830.0, Put dollar volume: $199050.0. The significant dominance of call volume suggests strong bullish conviction.

Pure Directional Positioning: The near-term expectations are strongly bullish, as indicated by the options flow.

Key Price Levels:

25-Day Price Forecast:

INSM is projected for $130.00 to $145.00 based on current technical trends, momentum, and indicators.

The forecast considers the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR). Support and resistance levels may act as barriers or targets.

Defined Risk Strategy Recommendations:

Based on the price forecast of $130.00 to $145.00:

• Bull Call Spread: Buy INSM 261016C00125000 (strike 125.0, price 9.6) and sell INSM261016C00135000 (strike 135.0, price 5.1). Net debit: 4.5, Max profit: 5.5, Max loss: 4.5, Breakeven: 129.5.
• Iron Condor: Sell INSM261016P00120000 (strike 120.0, price 2.6) and INSM261016C00130000 (strike 130.0, price 6.9), buy INSM261016P00115000 (strike 115.0, price 3.8) and INSM261016C00135000 (strike 135.0, price 5.1). Net credit: 1.2, Max profit: 1.2, Max loss: 4.8, Breakeven: 116.2, 133.8.

Risk Factors:

• Technical warning signs: Overbought conditions near $130.00.
• Sentiment divergences: None observed.
• Volatility and ATR: Recent volatility may increase.

Summary & Conviction Level:

Overall Bias: Bullish

Conviction Level: High

One-line Trade Idea: INSM shows bullish momentum with strong institutional buying and positive news.

View INSM Options Chain